Related Experiment Video
Updated: Sep 11, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
p16INK4a, but not constitutively active pRb, can impose a sustained G1 arrest: molecular mechanisms and implications
J Lukas1, C S Sørensen, C Lukas
1Institute of Cancer Biology, Danish Cancer Society, Copenhagen.
Abstract:
p16ink4 and pRb, two components of a key G1/S regulatory pathway, and tumor suppressors commonly targeted in oncogenesis, are among the candidates for gene therapy of cancer. Wild-type p16 and a constitutively active pRb(delta cdk) mutant both blocked G1 in short-term experiments, but only p16 imposed a sustained G1 arrest. Unexpectedly, cells conditionally exposed to pRb(delta cdk) entered S phase after 2 days, followed by endoreduplication between days 4-6. The distinct phenotypes evoked by p16 vs pRb(delta cdk) appear mediated by cyclin E/CDK2 which, while active in the pRb(delta cdk)-expressing cells, became rapidly inhibited through restructuring diverse cyclin/CDK/p21 complexes by p16. These results provide novel insights into the roles of p16, pRb and cyclin E in G1/S control and multistep oncogenesis, with implications for gene therapy strategies.
Insights
p16INK4 and pRb, key cell cycle regulators and tumor suppressors, show distinct effects in cancer gene therapy. p16INK4 induces sustained G1 arrest, while pRb(delta cdk) causes transient arrest and endoreduplication.
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Cancer Genetics
Background:
- p16INK4 and retinoblastoma protein (pRb) are crucial G1/S phase regulators and tumor suppressors.
- These proteins are frequently targeted in cancer gene therapy strategies.
Purpose of the Study:
- To investigate the distinct cellular responses to p16INK4 and a constitutively active pRb mutant (pRb(delta cdk)).
- To elucidate the roles of p16INK4, pRb, and cyclin E in G1/S control and oncogenesis.
- To assess the implications for cancer gene therapy.
Main Methods:
- Short-term and conditional expression experiments in cell cultures.
- Analysis of cell cycle progression (G1 arrest, S phase entry, endoreduplication).
- Investigation of cyclin/CDK complexes and p21 interactions.
Main Results:
- Both wild-type p16INK4 and pRb(delta cdk) initially blocked G1 phase.
- p16INK4 induced a sustained G1 arrest.
- pRb(delta cdk) led to transient G1 arrest, followed by S phase entry and endoreduplication.
- Distinct phenotypes were mediated by cyclin E/CDK2 activity, inhibited by p16INK4 but active in pRb(delta cdk)-expressing cells.
Conclusions:
- p16INK4 and pRb(delta cdk) exert differential control over G1/S transition.
- p16INK4 actively restructures cyclin/CDK/p21 complexes to inhibit cyclin E/CDK2.
- These findings offer new insights into cell cycle control, multistep oncogenesis, and cancer gene therapy approaches.
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
DNA Damage Can Stall the Cell Cycle

